Precision-based diagnostic approaches can help us improve patient outcomes and reach patient success sooner
Michael D. Howell, Ph.D.
Advertisement
Michael D. Howell, Ph.D., is Chief Scientific Officer of DermTech.
Articles by Michael D. Howell, Ph.D.
Advertisement
Latest Updated Articles
Precision-based DiagnosticsPublished: May 3rd 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Merck Begins Construction on $3 Billion Pharmaceutical Center of Excellence in Virginia
2
HDA 2025 Traceability Seminar: FDA Emphasizes Readiness Over Perfection
3
